Jupiter Neurosciences Delays Q2 Financial Report

Jupiter Neurosciences, Inc. ( (JUNS) ) has released a notification of late filing.

Jupiter Neurosciences, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The company cited the need for additional time to complete the presentation and review of its financial statements and related disclosures as the primary reason for the delay. Despite this setback, Jupiter Neurosciences anticipates filing the report within five calendar days following the prescribed due date. Importantly, the company does not expect any significant changes in its financial results compared to the corresponding period last year. The notification was signed by Christer Rosén, the Chief Executive Officer, who assured stakeholders of ongoing compliance efforts.

The most recent analyst rating on (JUNS) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Jupiter Neurosciences, Inc. stock, see the JUNS Stock Forecast page.

More about Jupiter Neurosciences, Inc.

Average Trading Volume: 531,015

Technical Sentiment Signal: Hold

Current Market Cap: $36.75M

Learn more about JUNS stock on TipRanks’ Stock Analysis page.